You are here: Industry Insights > SARS-CoV-2

News List

Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment worldpharmanews
September 01, 2020
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced that the first patient was dosed last week in a phase 2/3 study with VIR-7831 (also known as GSK4182136), a fully human anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus-2) ...
HiFiBiO submits IND application for SARS-CoV-2 neutralising antibody to treat Covid-19 patients pharmaceutical-business-review
August 31, 2020
HiFiBiO Therapeutics announced the submission of an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for a novel SARS-CoV-2 neutralizing antibody for the treatment of Covid-19 patients.
Further £8.4 million in funding given to UK researchers studying immune response to COVID-19 europeanpharmaceuticalreview
August 31, 2020
The funding is being split across three research projects that will hopefully improve the treatment of COVID-19 and inform the development of vaccines and therapeutics.
Active ingredient in insect repellent may protect against COVID-19: UK study expresspharma
August 31, 2020
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface.
University of Sheffield joins UK Coronavirus Immunology Consortium for COVID-19 research expresspharma
August 31, 2020
The Sheffield team will investigate how the body’s immune system responds to infection and also examine how T cells contribute to immunity to the virus to prevent re-infection.
Researcher claims antiviral medicine for cats also works against COVID-19 expresspharma
August 31, 2020
The scientists said they plan to test modifications of the drug to make it an even better fit inside the virus.
Search for COVID-19 drugs boosted by SARS discovery worldpharmanews
August 28, 2020
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.
NIHR, UKRI stream £8.4m into coronavirus studies pharmatimes
August 28, 2020
NIHR and UK Research and Innovation (UKRI) are streaming £8.4 million into three new UK-wide research studies aiming to understand immune responses to the novel coronavirus.
Akers Biosciences, Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results americanpharmaceuticalreview
August 28, 2020
Akers Biosciences announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conducted during a 4 week test of its SARS-CoV-2 vaccine candidate in mice.
New York Blood Center Research Confirms Effectiveness of Rapid Serological Test for COVID-19 americanpharmaceuticalreview
August 28, 2020
The New York Blood Center Lindsley F. Kimball Research Institute announced the results of an independent study that showed the Clungene® SARS-CoV-2 Virus (COVID-19) IgG/IgM Rapid Test Cassette possesses a high degree of sensitivity and specificity for ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page